COVID-19 Pandemic (Coronavirus)
- Thread starter null
- Start date
US also partly to blame for this. The world is looking up to US for guidance, so when US government didn't take the virus seriously the entire world also let their guard down.
Been saying this from time. Other countries took the US's lack of response and fell back. Trump's election has had a devastating impact on the entire world.
Keep_It_Hip_Hop_Fam
All Star
i was out earlier and white folks seemed to have said fukk the masks. even the stores that say if you don't have a face covering you can't come in they walk right in with no face coverings with their nasty asses and the store clerks seem too afraid to speak up.
It seems like the whole state has said fuk it, the next couple of weeks should be interesting
China deserves some criticism but the US saw the damn thing spreading for months and did nothing.
Imagine all the customers they infected
spencerforhire
All Star
This is some good news
https://www.wivb.com/health/coronav...-remdesivir-could-reach-patients-within-days/
Gilead CEO says coronavirus drug remdesivir could reach patients within days
Washington — Following the Food and Drug Administration’s authorization of the antiviral drug remdesivir for emergency use as a coronavirus treatment, the head of Gilead Sciences said Sunday he expects the medicine will be delivered for patients hospitalized with COVID-19 in the coming days.
“We are now firmly focused on getting this medicine to the most urgent patients around the country here in the United States,” Daniel O’Day, CEO of Gilead, said on “Face the Nation.” “We intend to get that to patients in the early part of this next week, beginning to work with the government, which will determine which cities are most vulnerable and where the patients are that need this medicine.”
Food and Drug Administration Commissioner Stephen Hahn announced Friday that remdesivir, produced by Gilead, received an emergency use authorization for the treatment of patients in the hospital with COVID-19.
A recently completed study led by the National Institutes of Health found that remdesivir shortened the recovery time for some coronavirus patients by four days. The drug is administered by IV through either a five-day treatment course or 10-day treatment course depending on the patient. O’Day said Gilead scientists are working to determine whether there are other ways the drug can be delivered.
Gilead has donated the entirety of its supply of remdesivir, O’Day said, which is roughly 1.5 million vials, or 100,000 to 200,000 treatment courses depending on the length of treatment.
“We did that because we acknowledge and recognize the human suffering, the human need here and want to make sure that nothing gets in the way of this getting to patients,” he said.
The federal government will now determine where to send the drug, using criteria such as ICU beds and the course of the epidemic in the U.S., O’Day said.
“They will begin shipping tens of thousands of treatment courses out early this week and be adjusting that as the epidemic shifts and evolves in different parts, in different cities here in the United States,” he said.
Not only will remdesivir be available to COVID-19 patients in the U.S., it will also be exported to other countries once they make regulatory decisions, according to O’Day. He said that Gilead expects to have more supply of remdesivir in the second half of 2020 “to serve the suffering and the human needs out there.”
“We’ve been working very closely with the U.S. government and with other governments around the world,” O’Day said. “In terms of the allocation question, I think we’re aligned with the US government to both serve the patients here in the United States and then to be able to also make sure, as a global company based here in the United States, that we can serve other countries around the world as well.”
https://www.wivb.com/health/coronav...-remdesivir-could-reach-patients-within-days/
Gilead CEO says coronavirus drug remdesivir could reach patients within days
Washington — Following the Food and Drug Administration’s authorization of the antiviral drug remdesivir for emergency use as a coronavirus treatment, the head of Gilead Sciences said Sunday he expects the medicine will be delivered for patients hospitalized with COVID-19 in the coming days.
“We are now firmly focused on getting this medicine to the most urgent patients around the country here in the United States,” Daniel O’Day, CEO of Gilead, said on “Face the Nation.” “We intend to get that to patients in the early part of this next week, beginning to work with the government, which will determine which cities are most vulnerable and where the patients are that need this medicine.”
Food and Drug Administration Commissioner Stephen Hahn announced Friday that remdesivir, produced by Gilead, received an emergency use authorization for the treatment of patients in the hospital with COVID-19.
A recently completed study led by the National Institutes of Health found that remdesivir shortened the recovery time for some coronavirus patients by four days. The drug is administered by IV through either a five-day treatment course or 10-day treatment course depending on the patient. O’Day said Gilead scientists are working to determine whether there are other ways the drug can be delivered.
Gilead has donated the entirety of its supply of remdesivir, O’Day said, which is roughly 1.5 million vials, or 100,000 to 200,000 treatment courses depending on the length of treatment.
“We did that because we acknowledge and recognize the human suffering, the human need here and want to make sure that nothing gets in the way of this getting to patients,” he said.
The federal government will now determine where to send the drug, using criteria such as ICU beds and the course of the epidemic in the U.S., O’Day said.
“They will begin shipping tens of thousands of treatment courses out early this week and be adjusting that as the epidemic shifts and evolves in different parts, in different cities here in the United States,” he said.
Not only will remdesivir be available to COVID-19 patients in the U.S., it will also be exported to other countries once they make regulatory decisions, according to O’Day. He said that Gilead expects to have more supply of remdesivir in the second half of 2020 “to serve the suffering and the human needs out there.”
“We’ve been working very closely with the U.S. government and with other governments around the world,” O’Day said. “In terms of the allocation question, I think we’re aligned with the US government to both serve the patients here in the United States and then to be able to also make sure, as a global company based here in the United States, that we can serve other countries around the world as well.”
How much u getting paid to be a guinea pig?
T-K-G
Veteran
Was with you until this
Never said that or assumed it, you shadowboxing right now breh
Blackrogue
Superstar
The Tanzanian president believes there's more than meets the eye to this thing and wants to do herd immunity if anything.
Every piece of equipment in the test kits is coming from outside. They sent in samples with some peoples names and some of them came back positive for Coronavirus ... Only problem is the positive results were from paw paws trees, sheep and goats that had been given human names.
He's done a press conference on this and challenged other people to try that blind test
Every piece of equipment in the test kits is coming from outside. They sent in samples with some peoples names and some of them came back positive for Coronavirus ... Only problem is the positive results were from paw paws trees, sheep and goats that had been given human names.
He's done a press conference on this and challenged other people to try that blind test
Walmart is going to have one of the biggest class action lawsuit of all time. Followed by Tyson chicken